China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates
- Revenue Increased 23.1% Y-O-Y to $15.5 Million - - 9-Month Net Cash Flow from Operations Reached $6.4 Million - - China Pharma Holdings Stock Began Trading on NYSE/AMEX - HAIKOU CITY, China, Nov. 11 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE/AMEX...
China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 2009
HAIKOU CITY, China, Oct. 28 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release third quarter 2009 financial results on Thursday, Novemb...
China Pharma Holdings, Inc. to Present at the Roth China Conference on October 14 at 12:00 pm ET
HAIKOU CITY, China, Oct. 12 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it will present at the Roth China Conference, to be held Octo...
China Pharma Holdings, Inc. Announces Approval for NYSE Amex Listing
HAIKOU CITY, China, Sept. 29 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has received approval to list its securities on NYSE Amex. ...
China Pharma Holdings, Inc. Announces Participation in September Conferences
HAIKOU CITY, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced it will participate in the following conferences: -- ...
China Pharma Holdings, Inc. Announces SFDA Approval for Production of Omeprazole Injections
Broadens Product Offerings for Multiple Therapeutic Markets HAIKOU CITY, China, Aug. 18 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced...
China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates
Revenue Increases 20.6% Year Over Year to $13.6 Million HAIKOU CITY, China, Aug. 12 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced financial...
China Pharma Holdings, Inc. to Report Second Quarter 2009 Financial Results on August 12, 2009
HAIKOU CITY, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release second quarter 2009 financial results...
China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials
Company to Enter Phase I and Phase II Clinical Trials for Generic Crestor(R) HAIKOU CITY, China, June 22 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in Ch...
China Pharma Holdings, Inc. Reports First Quarter 2009 Financial Results
-- Revenue Increased 10.9% Y-O-Y to $13.0 million -- -- Great Potential for New Products and Continued Strong Demand for Existing Products -- -- Increased Marketing Efforts and Distribution Expansion to Drive Future Revenue -- HAIKOU CITY, China, May 15 /PRNewswire-Asia-FirstCall/...
China Pharma Holdings, Inc. to Report First Quarter 2009 Financial Results on May 15, 2009
HAIKOU CITY, China, May 7 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release first quarter 2009 financial results on Friday, M...
China Pharma Holdings, Inc. Retains Global Investor Communications Team
HAIKOU CITY, China, May 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has retained ICR to advise the Company on investor co...
China Pharma Holdings, Inc. Appoints Chief Financial Officer and Board Member
HAIKOU CITY, China, April 30 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has appointed Mr. Frank Waung to Chief Financial Officer, and h...
China Pharma Holdings, Inc. Reports Record 2008 Year End Financial Results and Corporate Updates
Financial Highlights -- Fiscal year Revenue up 53.6%, to $50.96 Million, exceeding guidance of 45% -- Fiscal year Net Income up 39.1%, to 17.83 Million -- Fiscal year Gross Margin 49.6%, up from 46.9% for 2007 -- EPS increased 28% reaching $0.44 per share co...
China Pharma Holdings, Inc. to Host Fourth Quarter 2008 Earnings Conference Call at 8:30 a.m. EDT Wednesday March 18, 2009
NEW YORK and HAIKOU CITY, China, March 12 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets specialty pharmaceutical products in China, today announced it will release its Fourth Quarter 2008 results on Wednesda...
China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
Company initiated clinical trials for leading hypertension drug in China HAIKOU CITY, China, Feb. 11 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, an...
China Pharma Holdings, Inc., Financial Year 2008 Preview
- Record High Revenue for Financial Year 2008 - Sales Revenue up 50%, Net Income up 35% on Financial Year 2007 - Record High Positive Cash-flow in Operating Activities HAIKOU CITY, China, Jan. 21 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OT...
China Pharma Holdings, Inc. Receives SFDA Production Approval for Tiopronin Enteric-Coated Capsules
HAIKOU CITY, Hainan, China, Jan. 12 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that China's State Food and Drug Administration ("...
China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
HAIKOU CITY, China, Nov. 7 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets generic and branded speciality pharmaceutical products in China, today announced financial results for the quarter ended ...
China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
NEW YORK and HAIKOU CITY, China, Nov. 5 /Xinhua-PRNewswire-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio-pharmaceutical products in China, today announced it will release its third Quarter...
